1. Exposure‐Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product. Issue 1 (16th May 2022) Authors: Beliveau, Martin; Anderson, Deborah; Barker, Doug; Kodihalli, Shantha; Simard, Emilie; Hall, Christine; Richardson, Jason S. Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 1(2022) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetics and Macrophage Inhibitory Cytokine‐1 Pharmacodynamics of the Murine Double Minute 2 Inhibitor, Navtemadlin (KRT‐232) in Fed and Fasted Healthy Subjects. Issue 5 (16th February 2022) Authors: Wong, Shekman; Krejsa, Cecile; Lee, Dana; Harris, Anna; Simard, Emilie; Wang, Xiaohui; Allard, Martine; Podoll, Terry; O'Reilly, Terry; Slatter, J. Greg Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 5(2022) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa. (19th November 2021) Authors: Yi, B. Alexander; Freedholm, Debra; Widener, Nancy; Wang, Xiaohui; Simard, Emilie; Cullen, Constance; Al‐Saady, Naab M.; Lepor, Norman E.; Coulter, Sara; Lovern, Mark; Bloomfield, Dan Journal: Journal of thrombosis and haemostasis Issue: Volume 20:Number 2(2022) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗